These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

243 related items for PubMed ID: 9665481

  • 1. Activation of the urokinase plasminogen activator/urokinase plasminogen activator receptor system and redistribution of E-cadherin are associated with hepatocyte growth factor-induced motility of pancreas tumor cells overexpressing Met.
    Paciucci R, Vilá MR, Adell T, Díaz VM, Torà M, Nakamura T, Real FX.
    Am J Pathol; 1998 Jul; 153(1):201-12. PubMed ID: 9665481
    [Abstract] [Full Text] [Related]

  • 2. The geldanamycins are potent inhibitors of the hepatocyte growth factor/scatter factor-met-urokinase plasminogen activator-plasmin proteolytic network.
    Webb CP, Hose CD, Koochekpour S, Jeffers M, Oskarsson M, Sausville E, Monks A, Vande Woude GF.
    Cancer Res; 2000 Jan 15; 60(2):342-9. PubMed ID: 10667586
    [Abstract] [Full Text] [Related]

  • 3. The plasminogen activator system in pancreas cancer: role of t-PA in the invasive potential in vitro.
    Paciucci R, Torà M, Díaz VM, Real FX.
    Oncogene; 1998 Feb 05; 16(5):625-33. PubMed ID: 9482108
    [Abstract] [Full Text] [Related]

  • 4. Simultaneous up-regulation of urokinase-type plasminogen activator (uPA) and uPA receptor by hepatocyte growth factor/scatter factor in human glioma cells.
    Moriyama T, Kataoka H, Hamasuna R, Yoshida E, Sameshima T, Iseda T, Yokogami K, Nakano S, Koono M, Wakisaka S.
    Clin Exp Metastasis; 1999 Feb 05; 17(10):873-9. PubMed ID: 11089886
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Hepatocyte growth factor/scatter factor promotes retinal angiogenesis through increased urokinase expression.
    Colombo ES, Menicucci G, McGuire PG, Das A.
    Invest Ophthalmol Vis Sci; 2007 Apr 05; 48(4):1793-800. PubMed ID: 17389513
    [Abstract] [Full Text] [Related]

  • 7. Insulinlike growth factor-I-mediated migration and invasion of human colon carcinoma cells requires activation of c-Met and urokinase plasminogen activator receptor.
    Bauer TW, Fan F, Liu W, Johnson M, Parikh NU, Parry GC, Callahan J, Mazar AP, Gallick GE, Ellis LM.
    Ann Surg; 2005 May 05; 241(5):748-56; discussion 756-8. PubMed ID: 15849510
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Hepatocyte growth factor increases expression of vascular endothelial growth factor and plasminogen activator inhibitor-1 in human keratinocytes and the vascular endothelial growth factor receptor flk-1 in human endothelial cells.
    Wojta J, Kaun C, Breuss JM, Koshelnick Y, Beckmann R, Hattey E, Mildner M, Weninger W, Nakamura T, Tschachler E, Binder BR.
    Lab Invest; 1999 Apr 05; 79(4):427-38. PubMed ID: 10211995
    [Abstract] [Full Text] [Related]

  • 10. Presence of urokinase in serum-free primary rat hepatocyte cultures and its role in activating hepatocyte growth factor.
    Mars WM, Kim TH, Stolz DB, Liu ML, Michalopoulos GK.
    Cancer Res; 1996 Jun 15; 56(12):2837-43. PubMed ID: 8665523
    [Abstract] [Full Text] [Related]

  • 11. Extracellular proteolytic cleavage by urokinase is required for activation of hepatocyte growth factor/scatter factor.
    Naldini L, Tamagnone L, Vigna E, Sachs M, Hartmann G, Birchmeier W, Daikuhara Y, Tsubouchi H, Blasi F, Comoglio PM.
    EMBO J; 1992 Dec 15; 11(13):4825-33. PubMed ID: 1334458
    [Abstract] [Full Text] [Related]

  • 12. Activation of hepatocyte growth factor by urokinase-type plasminogen activator is ionic strength-dependent.
    Mars WM, Jo M, Gonias SL.
    Biochem J; 2005 Aug 15; 390(Pt 1):311-5. PubMed ID: 15869463
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Activation mechanisms of the urokinase-type plasminogen activator promoter by hepatocyte growth factor/scatter factor.
    Ried S, Jäger C, Jeffers M, Vande Woude GF, Graeff H, Schmitt M, Lengyel E.
    J Biol Chem; 1999 Jun 04; 274(23):16377-86. PubMed ID: 10347197
    [Abstract] [Full Text] [Related]

  • 18. Hepatocyte growth factor increases urokinase-type plasminogen activator (u-PA) and u-PA receptor expression in Madin-Darby canine kidney epithelial cells.
    Pepper MS, Matsumoto K, Nakamura T, Orci L, Montesano R.
    J Biol Chem; 1992 Oct 05; 267(28):20493-6. PubMed ID: 1328201
    [Abstract] [Full Text] [Related]

  • 19. Involvement of PI3K and ERK1/2 pathways in hepatocyte growth factor-induced cholangiocarcinoma cell invasion.
    Menakongka A, Suthiphongchai T.
    World J Gastroenterol; 2010 Feb 14; 16(6):713-22. PubMed ID: 20135719
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.